Annual Revenue
$18.72 M
-$12.53 M-40.09%
December 1, 2024
Summary
- As of March 14, 2025, ACRS annual revenue is $18.72 million, with the most recent change of -$12.53 million (-40.09%) on December 1, 2024.
- During the last 3 years, ACRS annual revenue has risen by +$11.96 million (+176.88%).
- ACRS annual revenue is now -40.09% below its all-time high of $31.25 million, reached on December 31, 2023.
Performance
ACRS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$9.21 M
+$4.87 M+111.94%
December 1, 2024
Summary
- As of March 14, 2025, ACRS quarterly revenue is $9.21 million, with the most recent change of +$4.87 million (+111.94%) on December 1, 2024.
- Over the past year, ACRS quarterly revenue has dropped by -$8.36 million (-47.58%).
- ACRS quarterly revenue is now -51.57% below its all-time high of $19.02 million, reached on September 30, 2022.
Performance
ACRS Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$18.72 M
-$8.36 M-30.87%
December 1, 2024
Summary
- As of March 14, 2025, ACRS TTM revenue is $18.72 million, with the most recent change of -$8.36 million (-30.87%) on December 1, 2024.
- Over the past year, ACRS TTM revenue has dropped by -$12.53 million (-40.09%).
- ACRS TTM revenue is now -41.53% below its all-time high of $32.02 million, reached on June 30, 2024.
Performance
ACRS TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ACRS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.1% | -47.6% | -40.1% |
| 3 y3 years | +176.9% | +513.7% | +176.9% |
| 5 y5 years | +342.9% | +554.7% | +328.3% |
ACRS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.1% | +176.9% | -51.6% | +533.9% | -41.5% | +204.8% |
| 5 y | 5-year | -40.1% | +342.9% | -51.6% | +741.2% | -41.5% | +342.9% |
| alltime | all time | -40.1% | +1012.3% | -51.6% | +1246.6% | -41.5% | +2637.0% |
Aclaris Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $18.72 M(-40.1%) | $9.21 M(+111.9%) | $18.72 M(-30.9%) |
| Sep 2024 | - | $4.35 M(+57.1%) | $27.08 M(-15.4%) |
| Jun 2024 | - | $2.77 M(+15.3%) | $32.02 M(+2.9%) |
| Mar 2024 | - | $2.40 M(-86.4%) | $31.12 M(-0.4%) |
| Dec 2023 | $31.25 M(+5.0%) | $17.57 M(+89.3%) | $31.25 M(+45.8%) |
| Sep 2023 | - | $9.28 M(+396.6%) | $21.43 M(-31.2%) |
| Jun 2023 | - | $1.87 M(-26.1%) | $31.17 M(+1.1%) |
| Mar 2023 | - | $2.53 M(-67.4%) | $30.83 M(+3.6%) |
| Dec 2022 | $29.75 M(+340.1%) | $7.75 M(-59.2%) | $29.75 M(+26.6%) |
| Sep 2022 | - | $19.02 M(+1144.6%) | $23.50 M(+282.7%) |
| Jun 2022 | - | $1.53 M(+5.2%) | $6.14 M(-4.6%) |
| Mar 2022 | - | $1.45 M(-3.2%) | $6.44 M(-4.8%) |
| Dec 2021 | $6.76 M | $1.50 M(-9.5%) | $6.76 M(-1.2%) |
| Sep 2021 | - | $1.66 M(-9.0%) | $6.84 M(+3.2%) |
| Jun 2021 | - | $1.82 M(+2.6%) | $6.63 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $1.78 M(+12.5%) | $6.85 M(+5.7%) |
| Dec 2020 | $6.48 M(+53.3%) | $1.58 M(+9.0%) | $6.48 M(+8.1%) |
| Sep 2020 | - | $1.45 M(-29.2%) | $6.00 M(+8.4%) |
| Jun 2020 | - | $2.05 M(+45.4%) | $5.53 M(+26.5%) |
| Mar 2020 | - | $1.41 M(+28.5%) | $4.37 M(+3.4%) |
| Dec 2019 | $4.23 M(-31.3%) | $1.09 M(+11.4%) | $4.23 M(-13.8%) |
| Sep 2019 | - | $983.00 K(+10.9%) | $4.90 M(-2.7%) |
| Jun 2019 | - | $886.00 K(-29.8%) | $5.04 M(-35.6%) |
| Mar 2019 | - | $1.26 M(-28.7%) | $7.83 M(+1.9%) |
| Dec 2018 | $6.15 M(+265.5%) | $1.77 M(+58.5%) | $7.68 M(+11.2%) |
| Sep 2018 | - | $1.12 M(-69.6%) | $6.91 M(+6.7%) |
| Jun 2018 | - | $3.68 M(+228.8%) | $6.48 M(+131.2%) |
| Mar 2018 | - | $1.12 M(+11.9%) | $2.80 M(+66.4%) |
| Dec 2017 | $1.68 M | $999.00 K(+46.1%) | $1.68 M(+146.1%) |
| Sep 2017 | - | $684.00 K | $684.00 K |
FAQ
- What is Aclaris Therapeutics annual revenue?
- What is the all time high annual revenue for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual revenue year-on-year change?
- What is Aclaris Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly revenue year-on-year change?
- What is Aclaris Therapeutics TTM revenue?
- What is the all time high TTM revenue for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM revenue year-on-year change?
What is Aclaris Therapeutics annual revenue?
The current annual revenue of ACRS is $18.72 M
What is the all time high annual revenue for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual revenue is $31.25 M
What is Aclaris Therapeutics annual revenue year-on-year change?
Over the past year, ACRS annual revenue has changed by -$12.53 M (-40.09%)
What is Aclaris Therapeutics quarterly revenue?
The current quarterly revenue of ACRS is $9.21 M
What is the all time high quarterly revenue for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly revenue is $19.02 M
What is Aclaris Therapeutics quarterly revenue year-on-year change?
Over the past year, ACRS quarterly revenue has changed by -$8.36 M (-47.58%)
What is Aclaris Therapeutics TTM revenue?
The current TTM revenue of ACRS is $18.72 M
What is the all time high TTM revenue for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM revenue is $32.02 M
What is Aclaris Therapeutics TTM revenue year-on-year change?
Over the past year, ACRS TTM revenue has changed by -$12.53 M (-40.09%)